Antimicrobial drug resistance: "Prediction is very difficult, especially about the future"

Emerging Infectious Diseases

Volumn 11, Issue 10, 2005, Pages 1503-1506

  Courvalin, Patrice ^a,b,c  

^a INSTITUT PASTEUR   (France)

^b French National Reference Center for Antibiotics   (France)

^c Antibacterial Agents Unit   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; GLYCOPEPTIDE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; BACTERIUM TRANSFORMATION; EVOLUTION; GENE EXPRESSION REGULATION; GENE MUTATION; HORIZONTAL GENE TRANSFER; HOUSEKEEPING GENE; MEMBRANE PERMEABILITY; MULTIDRUG RESISTANCE; NONHUMAN; PREDICTION; REGULATOR GENE; REVIEW; STRUCTURAL GENE;

EID: 25644434960     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1110.051014     Document Type: Review

References (33)

1. Courvalin P, Trieu-Cuot P. Minimizing potential resistance: the molecular view. Clin Infect Dis. 2001;33:S138-46.
2. Seppala H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis. 1995;21:1378-85.
3. Andersson DI. Persistence of antibiotic resistant bacteria. Curr Opin Microbiol. 2003;6:452-6.
4. Chiew YF, Yeo SF, Hall LM, Livermore DM. Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus Enterobacteriaceae. J Antimicrob Chemother. 1998;41:247-51.
5. Macrina FL, Archer GL. Conjugation and broad host range plasmids in streptococci and staphylococci. In: Clewell DB, editor. Bacterial conjugation. New York, London: Plenun Press; 1993. p. 313-29.
6. Charpentier E, Courvalin P. Antibiotic resistance in Listeria spp. Antimicrob Agents Chemother. 1999;43:2103-8.
7. Mazodier P, Davies J. Gene transfer between distantly related bacteria. Annu Rev Genet. 1991;25:147-74.
8. Walker MS, Walker JB. Streptomycin biosynthesis and metabolism. J Biol Chem. 1970;245:6683-9.
9. Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science. 2003;302:1569-71.
10. Moubareck C, Bourgeois N, Courvalin P, Doucet-Populaire F. Multiple antibiotic resistance gene transfer from animal to human enterococci in the digestive tract of gnotobiotic mice. Antimicrob Agents Chemother. 2003;47:2993-6.
11. Taddei F, Matic I, Godelle B, Radman M. To be a mutator, or how pathogenic and commensal bacteria can evolve rapidy. Trends Microbiol. 1997;5:427-8.
12. Petrosino J, Cantu III C, Palzkill T. β-Lactamases: protein evolution in real time. Trends Microbiol 1998;6:323-7.
13. Chen ST, Clowes RC. Variations between the nucleotide sequences of Tn1, Tn2, and Tn3 and expression of β-lactamase in Pseudomonas aeruginosa and Escherichia coli. J Bacteriol. 1987;169:913-6.
14. Baptista M, Depardieu F, Reynolds P, Courvalin P, Arthur M. Mutations leading to increased levels of resistance to glycopeptide antibiotics in VanB-type enterococci. Mol Microbiol. 1997;25:93-105.
15. Goussard S, Sougakoff W, Mabilat C, Bauernfeind A, Courvalin P. An IS1-like element is responsible for high-level synthesis of extended-spectrum β-lactamase TEM-6 in Enterobacteriaceae. J Gen Microbiol. 1991;137:2681-7.
16. Rudant E, Courvalin P, Lambert T. Characterization of IS18, an element capable of activating the silent aac(6′)-Ij gene of Acinetobacter sp. 13 strain BM2716 by transposition. Antimicrob Agents Chemother. 1998;42:2759-61.
17. Magnet S, Courvalin P, Lambert T. Activation of the cryptic aac(6′)-Iy aminoglycoside resistance gene of Salmonella by a chromosomal deletion generating a transcriptional fusion. J Bacteriol. 1999;181:6650-5.
18. Leclercq R, Courvalin P. Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2002;46:2727-34.
19. Courvalin P. Genotypic approach to the study of bacterial resistance to antibiotics. Antimicrob Agents Chemother. 1991;35:1019-23.
20. Ferrandiz MJ, Fenoll A, Liñares J, de la Campa AG. Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother. 2000;44:840-7.
21. Arthur M, Courvalin P. Contribution of two different mechanisms to erythromycin resistance in Escherichia coli. Antimicrob Agents Chemother. 1986;30:694-700.
22. Ferretti JJ, Gilmore KS, Courvalin P. Nucleotide sequence analysis of the bifunctional 6′-aminoglycoside acetyltransferase, 2″-aminoglycoside phosphotransferase determinant from Streptococcus faecalis: identification and cloning of gene regions specifying the two activities. J Bacteriol. 1986;167:631-8.
23. Sougakoff W, Goussard S, Gerbaud G, Courvalin P. Plasmid-mediated resistance to third-generation cephalosporins caused by point-mutations in TEM-type penicillinase genes. Rev Infect Dis. 1988;10:879-84.
24. Mabilat C, Courvalin P. Development of "oligotyping" for characterization and molecular epidemiology of TEM β-lactamases in members of the family Enterobacteriaceae. Antimicrob Agents Chemother. 1990;34:2210-6.
25. Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev. 2003;67:593-656.
26. Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs. 2004;64:159-204.
27. Ménard R, Molinas C, Arthur M, Duval J, Courvalin P, Leclercq R. Overproduction of 3′-aminoglycoside phosphotransferase type I confers resistance to tobramycin in Escherichia coli. Antimicrob Agents Chemother. 1993;37:78-83.
28. Magnet S, Smith TA, Zheng R, Nordmann P, Blanchard JS. Aminoglycoside resistance resulting from tight drug binding to an altered aminoglycoside acetyltransferase. Antimicrob Agents Chemother. 2003;47:1577-83.
29. Srinivasan A, Dick JD, Perl TM. Vancomycin resistance in staphylococci. Clin Microbiol Rev. 2002;15:430-8.
30. Courvalin P. Transfer of antibiotic resistance genes between gram-positive and gram-negative bacteria. Antimicrob Agents Chemother. 1994;38:1447-51.
31. Quintiliani Jr R, Sahm D, Courvalin P. Mechanisms of resistance to antimicrobial agents. In Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 7th ed. Washington: American Society for Microbiology; 1998. p. 1505-25.
32. Pootoolal J, Thomas MG, Marshall CG, Neu JM, Hubbard BK, Walsh CT, et al. Assembling the glycopeptide antibiotic scaffold: the biosynthesis of A47934 from Streptomyces toyocaensis NRRL15009. Proc Natl Acad Sci U S A. 2002;99:8962-7.
33. Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn1546, a Tn5-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol. 1993;175:117-27.